ANGO insider trading

NasdaqGS Healthcare

ANGIODYNAMICS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
564
Last 90 days
0
Buys / sells
3% / 5%
Market cap
$469.26M

About ANGIODYNAMICS INC

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Company website: www.angiodynamics.com

ANGO insider activity at a glance

FilingIQ has scored 564 insider transactions for ANGO since Jan 28, 2015. The most recent filing in our index is dated Oct 21, 2025.

Across the full history, 19 open-market purchases and 26 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ANGO insider trades is 58.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Politicians who have traded ANGO

Frequently asked

How many insider trades does FilingIQ track for ANGO?
FilingIQ tracks 564 Form 4 insider transactions for ANGO (ANGIODYNAMICS INC), covering filings from Jan 28, 2015 onwards. 0 of those were filed in the last 90 days.
Are ANGO insiders net buyers or net sellers?
Across the full Form 4 history for ANGO, 19 transactions (3%) were open-market purchases and 26 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ANGO insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ANGO in?
ANGIODYNAMICS INC (ANGO) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $469.26M.

Methodology & sources

Every ANGO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.